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A 68-year-old Caucasian man was admitted to the nephro-
logy department in October 2010 with recurrent fever,
hemolysis, and acute renal failure.
On review of his record, the patient was suffering from
hemolytic anemia since July 2010 (suspected autoimmune
hemolytic anemia with positive direct Coombs test) and
transient thrombocytopenia. Therapy with prednisolone
resulted in clinical improvement. Subsequently T-cell large
granular lymphocyte leukemia was suspected and treated
with methotrexate at 10mg per week from 23 July 2010 until
10 September 2010. The patient had previously received
splenectomy for hairy cell leukemia in 1986 (and had been in
remission since).
On admission, the physical examination was normal.
Laboratory tests showed a serum creatinine concentration
of 2.4mg/dl. Lactate dehydrogenase was elevated (2235U/l).
Red blood count showed a normocytic normochromic anemia,
with hemoglobin of 7.2mg/dl. The peripheral smear is shown
in Figure 1. Additional signs of hemolysis, such as decreased
haptoglobin and hyperbilirubinemia (1.27mg/dl), were pre-
sent. The reticulocyte count was elevated (8.9%). Antinuclear
antibodies were elevated (1:320), but other immunological
parameters (antimitochondrial antibodies, antineutrophilic
cytoplasmic antibodies, and antinuclear antibodies subsets)
were negative. ADAMTS (a disintegrin and metalloproteinase
with thrombospondin motifs)-13 activity was 83%. Urine
tested on dipstick was positive for heme with very few red
blood cells.
During the previous hospitalization in September 2010,
thoracical and abdominal contrast-enhanced computed
tomography revealed no signs of infection or process of
malignancy.
A renal biopsy showed moderate acute tubular injury and
minimal interstitial inflammation.
What is your diagnosis?
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Figure 1 |Peripheral blood (Giemsa staining,
print magnification 300 d.p.i.).
SEE NEXT PAGE FOR ANSWERS
Kidney International (2011) 80, 681–683 681
The Diagnosis | Babesiosis
The diagnosis of babesiosis was established on the basis of the
piriform shape and the plasmodium-like appearance of the
intraerythrocytic parasites (parasitemiaB30%), as shown in
Figure 1.
Testing for specific immunoglobulin (Ig) M and IgG
antibodies against Babesia spp. by immunofluorescence assay
was positive (1:1024). PCR from whole blood confirmed
Babesia venatorum, the recently described species (EU1
isolates), clustering within the B. divergens complex.
Serology excluded coinfections with Borrelia burgdorferi,
Rickettsia spp., early summer meningitis-encephalitis, and
ehrlichiosis.
Table 1 | Differential diagnosis of hemolysis and acute renal failure
Pathogenesis Signs and symptoms Lab findings
HUS Acute renal failure,
microangiopathic anemia
PT and aPTT normal, thrombocytopenia,
microangiopathic hemolytic anemia,
ADAMTS-13 activity normal, Coombs test
negative, schistocytes, hematuria, proteinuria
HUS (Dþ ) Infection with shiga-like toxin-producing
Escherichia coli (often children)
Diarrhea, abdominal cramps,
vomiting, fever, neurological
involvement possible
Stool cultures, antibodies against shiga-like
toxin-producing E. coli
Atypical HUS (HUS (D))
Familial HUS Genetic abnormalities of proteins involved in the
regulation of complement system-mutation in
factor H, I, B genes (complement regulatory
proteins), mutation in MCP gene encoding
membrane cofactor protein, heterozygous
mutations in the complement C3 gene
Mutation analysis, PCR
C3k, C4 normal
Sporadic HUS Viral infections, drugs, malignancies,
transplantation, pregnancy, scleroderma,
lupus, antiphospholipid syndrome, idiopathic
TTP (Moschowitz syndrome) Prodrome of fatigue, nausea,
pallor, petechiae, purpura,
epistaxis, fever, jaundice,
neurological deficits, abdominal
pain, hepatomegaly,
splenomegaly, multiple
organ involvement
PT and aPTT normal, thrombocytopenia,
microangiopathic hemolytic anemia,
Coombs test negative, schistocytes,
hematuria, proteinuria
Sporadic TTP Pregnancy, transplantation, drugs, HIV,
lupus, malignancies
Idiopathic TTP Autoantibody-mediated ADAMTS-13 deficiency
ADAMTS-13 activity reduced
Hereditary TTP Homozygous or double heterozygous
ADAMTS-13 mutations
Hemolytic anemia
PNH
(Marchiafava–Micheli
syndrome)
Non-malignant clonal expansion of one or several
hematopoietic stem cells with acquired somatic
mutation of PIG-A gene-deficiency in glycosyl-
phosphatidyl-inositol-anchored complement
regulatory proteins CD55 and CD59
Clinical evidence of paroxysmal
intravascular hemolysis with
fatigue, shortness of breath,
palpitations, thrombosis
(pulmonary embolism, portal
venous thrombosis, mesenteric
ischemia, stroke), renal failure,
hemoglobinuria
Hemolytic anemia with or without
thrombopenia or neutropenia, Coombs
test negative, hematuria, hemosiderinuria,
thrombosis, acetylcholinesterasis deficiency
in erythrocytes, sugar lysis test for screening,
more specific Ham’s acid hemolysis test, if
positive-flow cytometry for CD55 and CD59
Autoimmune hemolytic
anemia
Warm autoantibodies (mostly IgG), eventually
triggered by non-steroidal anti-inflammatory
drugs and cephalosporins; associated with
infections, autoimmune disease, malignancies
Signs of intravascular hemolysis
with fatigue, shortness of breath,
jaundice, splenomegaly, renal
failure
Hemolytic anemia, Coombs test positive,
hematuria
Infectious anemia Malaria, thick borne disease Hemolytic anemia, Coombs test might
be positive, hematuria, peripheral
blood smear with protists
Abbreviations: ADAMTS, a disintegrin and metalloproteinase with thrombospondin motifs; aPTT, activated partial thromboplastin time; HUS, hemolytic uremic syndrome;
HUS (Dþ ), diarrheal HUS; HUS (D), nondiarrheal HUS; IgG, immunoglobulin G; PNH, paroxysmal nocturnal hemoglobinuria; PT, prothrombin time; TTP, thrombotic
thrombocytopenic purpura.
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Babesiosis, a worldwide disease, was primarily known as a
zoonotic-emerging tick-transmitted disease of mainly veter-
inary importance in cattle but also in horses, sheep, pigs, deer,
and dogs.1 Infections in humans are accidental. In the northern
and mid-western regions of the United States, the main
etiological agent of human babesiosis is B. microti, whereas
most cases in Europe have been caused by B. divergens. These
infections mainly occurred in asplenic patients.2
Symptoms of B. divergens infection tend to appear with
abrupt onset following an incubation period of 1–3 weeks.
Clinical manifestations of severe illness due to babesiosis may
include a shock-like picture with renal failure and pulmonary
edema.2
Babesia venatorum (EU 1) was first described by Herwaldt
et al.3 So far, only three cases of human babesiosis, where
Babesia spp. EU 1 was identified, have been reported.
The clinical manifestations in the described cases were
mild to moderate, with fatigue, dark urine, headache,
jaundice, lethargy, and fever (391C). The parasitemia ranged
from 1 to 30%. All the three cases recovered after therapy. In
the follow-up, eventually no parasitemia was found.
A confusing aspect of babesiosis—direct Coombs-positive
hemolytic anemia—may lead to a delay in diagnosis as in
our case.
In October 2010, treatment with quinine (500mg, t.i.d.,
p.o.) and clindamycin (600mg, t.i.d., p.o.) was initiated and
continued for 10 days. The dosage of the prednisolone
therapy was tapered slowly. The patient showed good clinical
response to treatment, and parasites could no longer be
detected in peripheral blood smears.
In summary, we conclude that in unusual cases of
hemolysis and acute renal failure babesiosis should be
considered especially in immunocompromised subjects such
as patients after splenectomy, as in the presented report.
Adequate diagnosis and appropriate treatment lead to rapid
remission (Table 1).
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